ENDRA Life Sciences Inc. — Proxy Solicitation & Information Statement 2020

Apr 29, 2020

DEFA14A 1 ndra_defa14a.htm NOTICE AND ACCESS CARD Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com Copyright 2020 Issuer Direct Corporation Unassociated Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No. __)

EFPlaceholder Filed by the Registrant ☑

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, For Use of the Commission Only (As Permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

☑ Definitive Additional Materials

☐ Soliciting Material under Rule 14a-12

ENDRA Life Sciences Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant)

Payment of Filing Fee (Check the appropriate box):

☑ No fee required

☐ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1) Title of each class of securities to which transaction applies:

(2) Aggregate number of securities to which transaction applies:

(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

(4) Proposed maximum aggregate value of transaction:

(5) Total fee paid:

☐ Fee paid previously with preliminary materials.

☐ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.

(1) Amount Previously Paid:

(2) Form, Schedule or Registration Statement No.:

(3) Filing Party:

(4) Date Filed:

EFPlaceholder

EFPlaceholder

page break

ENDRA Life Sciences Inc.
	REQUEST ID:
IMPORTANT NOTICE
REGARDING THE AVAILABILITY OF PROXY MATERIALS for the Annual Meeting of
Stockholders
DATE:	TUESDAY, June 16, 2020
TIME:	10:00 A.M. EASTERN TIME
LOCATION:	https://www.issuerdirect.com/virtual-event/ndra

HOW TO REQUEST PAPER COPIES OF OUR MATERIALS — PHONE: Call toll free 1-866-752-8683	FAX: Send this card to 202-521-3464	INTERNET: https://www.iproxydirect.com/NDRA and follow the on-screen instructions.	EMAIL: proxy@iproxydirect.com Include your Control ID in your email

| This communication represents a
notice to access a more complete set of proxy materials available
to you on the Internet. We encourage you to access and review all
of the important information contained in the proxy materials
before voting. The proxy statement is available at: https://www.iproxydirect.com/NDRA |
| --- |
| If you want to receive a paper copy of the proxy materials you must
request one. There is no charge to you for requesting a copy. To
facilitate timely delivery please make the request, as instructed
above, before June 2, 2020. |
| you may enter your voting instructions at: https://www.iproxydirect.com/NDRA until
POLLS ARE CLOSED AT THE ANNUAL MEETING. |

| The purposes of this meeting are as follows: |
| --- |
| 1. to
elect six (6) nominees to the Board of Directors as nominated by
the Board of Directors: Francois Michelon, Louis J. Basenese,
Anthony DiGiandomenico, Dr. Sanjiv Sam Gambhir,Michael Harsh, and
Alexander Tokman. 2. To
approve an amendment to the Company’s Certificate of
Incorporation increasing the number of authorized shares of common
stock from 50,000,000 shares to 80,000,000
shares . 3. To
ratify the appointment of RBSM LLP as the Company’s
independent registered public accounting firm for
2020. |

| Pursuant to Securities and Exchange Commission rules, you are
receiving this Notice that the proxy materials for the Annual
Meeting are available on the Internet. Follow the instructions
above to view the materials and vote or request printed
copies. The board of directors has fixed the
close of business on April, 22 2020 as the record date for the
determination of stockholders entitled to receive notice of the
Annual Meeting and to vote the shares of our common stock, par
value $0.0001 per share, and our preferred stock, par value $0.0001
per share, they held on that date at the meeting or any
postponement or adjournment of the meeting. stockholders will be
able to view a list of stockholders of record as of the record date
at https://www.iproxydirect.com/NDRA |
| --- |
| The Board of Directors recommends that you vote ‘for’
all proposals above. |
| Please note - This is not a Proxy Card - you cannot vote by
returning this card. |

page break

ENDRA LIFE SCIENCES INC. SHAREHOLDER SERVICES 1 Glenwood Avenue Suite 1001 Raleigh NC 27603 FIRST-CLASS MAIL US POSTAGE PAID RALEIGH NC PERMIT # 870

TIME SENSITIVE SHAREHOLDER INFORMATION ENCLOSED

IMPORTANT SHAREHOLDER INFORMATION

YOUR VOTE IS IMPORTANT

page break